Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HU, Shaoxian
CCR-DDR, NCT05284942: Central China Rosai-Dorfman Disease Registry	Recruiting	4	20	RoW	Mycophenolate mofetil combined with oral prednisone	Tongji Hospital	Rosai-Dorfman Disease, Langerhans Cell Histiocytosis	06/22	06/22
NCT05303285: A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis	Recruiting	4	100	RoW	Secukinumab 300mg s.c., AIN457, Cosentyx, Secukinumab 150mg s.c.	Tongji Hospital, Wuhan Central Hospital, Wuhan Hospital of Traditional Chinese Medicine	Ankylosing Spondylitis (AS)	08/22	08/22
NCT05303272: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)	Recruiting	4	60	RoW	Abatacept Prefilled Syringe, Orencia, Mycophenolate Mofetil 500Mg Tab, MMF,CellCept	Tongji Hospital, Wuhan Central Hospital, Wuhan Hospital of Traditional Chinese Medicine	Pemphigus Vulgaris	09/22	09/22
NCT05300932: A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis	Recruiting	4	60	RoW	Baricitinib, Olumiant, Cyclophosphamide, Cytoxan	Tongji Hospital	Systemic Sclerosis	03/23	04/23